ManagedCareCGM

This site is intended for managed care professionals in the U.S.

This site is intended for managed care professionals in the U.S.

Professionals in Canada should visit CanadaCGM.com

Continuous Glucose Monitoring

Education for Managed Care, Pharmacy, and Payer Professionals

Interviews

Expert Interview Series with Professor Thomas Danne

Expert: Thomas Danne, MD, Professor of Pediatrics, Children’s Hospital Auf der Bult, Hanover, Germany

Part 1 – Glycemic Control: Opportunities and Challenges

References:
International Consensus on Use of Continuous Glucose Monitoring
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range 

Part 2 – Time in Range and Reduction in Diabetes-Related Complications

References:
Going Beyond A1c – One Outcome Can’t Do It All
Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
Continuous Glucose Monitoring in Adults with Type 1 Diabetes: Real-World Data from the German/Austrian Prospective Diabetes Follow-Up Registry

Part 3 – Virtual Care and the Future of CGM


References:
Acceptability and Utilization of Newer Technologies and Effects on Glycemic Control in Type 2 Diabetes: Lessons Learned from Lockdown
Blood Glucose Control During Lockdown for COVID-19: CGM Metrics in Italian Adults With Type 1 Diabetes
Personal Experience With COVID-19 and Diabetes in the South of France: Technology Facilitates the Management of Diabetes in Disruptive Times

Expert Interview

Appropriate Utilization Management Strategies for Continuous Glucose Monitoring

Expert: Jeffrey D. Dunn, PharmD, MBA, (Formerly) Vice President, Clinical Strategy and Programs and Industry Relations at Magellan Rx Management